You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Drugs

The drug library provides access to information on over 100 cancer drugs available for use in Canada.

Displaying Drugs List

20 Items
Other Name(s): Proleukin® (interleukin-2) (Novartis)
Funding:
New Drug Funding Program
  • Aldesleukin (interleukin-2) - In-Transit Metastases from Melanoma
Jan 2017
Other Name(s): Bavencio(TM) (EMD Serono (distributor))
Updated
Feb 2018
Other Name(s): Paraplatin AQ® (multiple brands available)
Aug 2016
Other Name(s): Erbitux® (Imclone)
Funding:
New Drug Funding Program
  • Cetuximab and Radiation - Locally Advanced Squamous Cell Carcinoma of the Head and Neck
  • Cetuximab with Irinotecan - Third Line - Metastatic Colorectal Small Bowel or Appendiceal Cancer
Jun 2017
Other Name(s): Platinol AQ® (multiple brands available)
Aug 2016
Other Name(s): Cotellic™ (Hoffman-La Roche)
Funding:
Exceptional Access Program
  • cobimetinib - For combination therapy (with vemurafenib) for the treatment of patients with previously untreated BRAF V600 mutation-positive unresectable stage III or IV melanoma
Dec 2017
Other Name(s): Tafinlar® (Novartis)
Funding:
Exceptional Access Program
  • daBRAfenib - As monotherapy for the first-line and second-line treatment of patients with BRAF V600 mutation-positive unresectable melanoma or metastatic disease, according to specific criteria
  • daBRAfenib - In combination with trametinib for the treatment of BRAF V600 mutation-positive, unresectable or metastatic melanoma and other indications, according to specific clinical criteria
Aug 2017
Other Name(s): DTIC® (generic brand available)
Aug 2016
Other Name(s): Vepesid® (multiple brands available)
Funding:
ODB - General Benefit
  • etoposide - oral capsules
Nov 2017
Other Name(s): Adrucil® (multiple brands available); Efudex® Cream (Valeant)
Aug 2016
Other Name(s): Intron A® (Merck)
Funding:
New Drug Funding Program
  • Interferon - Melanoma
ODB Limited Use
  • interferon alfa-2b - For hairy cell leukemia and Kaposi's Sarcoma
Aug 2016
Other Name(s): Yervoy® (Bristol-Myers Squibb)
Funding:
New Drug Funding Program
  • Ipilimumab - Previously Untreated Advanced Unresectable Melanoma
  • Ipilimumab - Previously Treated Advanced Unresectable Melanoma
Nov 2017